Literature DB >> 303520

Circulating immune complexes and antinuclear antibodies in juvenile rheumatoid arthritis.

R D Rossen, E J Brewer, D A Person, J W Templeton, M D Lidsky.   

Abstract

Materials with the Clq binding properties of soluble immune complexes (IC) were found in sera from 11 of 51 consecutive (22%) children with juvenile rheumatoid arthritis (JRA) and in 17 of 20 adults with active seropositive rheumatoid arthritis (RA). IC appeared more frequently in children with systemic onset disease whereas antinuclear antibody (ANA) was found more frequently in sera from those with pauciarticular disease. Only 3 JRA sera contained anti-immunoglobulin (rheumatoid factor); those 3 also had high Clq binding activities. Seven of 50 patients (14%) carried HLA-B27 but B27 was not associated with high Clq binding activity or presence of ANA. The presence of free ANA more frequently in children with mild disease and IC more frequently in children with relatively severe disease suggests that children with systemic JRA may have a relative defect in antibody-forming capacity or reticuloendothelial function which results in decreased clearance of circulating IC. Alternatively, systemic, polyarticular, and pauciarticular JRA may represent a spectrum of clinically similar diseases resulting from different etiologic agents.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 303520     DOI: 10.1002/art.1780200807

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  8 in total

Review 1.  Juvenile chronic arthritis, chronic iridocyclitis, and reactivity to histones.

Authors:  A M Leak; P Woo
Journal:  Ann Rheum Dis       Date:  1991-09       Impact factor: 19.103

Review 2.  Familial rheumatoid arthritis: linkage of HLA to disease susceptibility locus in four families where proband presented with juvenile rheumatoid arthritis.

Authors:  R D Rossen; E J Brewer; R M Sharp; J Ott; J W Templeton
Journal:  J Clin Invest       Date:  1980-03       Impact factor: 14.808

3.  Immune complexes in juvenile chronic arthritis.

Authors:  U Latzka; E J Menzel; W Granninger; C Steffen
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

Review 4.  Autoantibody profile in juvenile chronic arthritis.

Authors:  A M Leak
Journal:  Ann Rheum Dis       Date:  1988-03       Impact factor: 19.103

5.  Serological abnormalities in juvenile chronic arthritis: a review of 46 cases.

Authors:  Z Balogh; K Merétey; A Falus; S Bozsóky
Journal:  Ann Rheum Dis       Date:  1980-04       Impact factor: 19.103

6.  Antigen-antibody complexes in the serum of patients with juvenile chronic arthritis.

Authors:  H Moran; B M Ansell; J F Mowbray; R J Levinsky; J F Soothill
Journal:  Arch Dis Child       Date:  1979-02       Impact factor: 3.791

7.  Antinuclear antibody studies in juvenile chronic arthritis.

Authors:  A M Leak; B M Ansell; S J Burman
Journal:  Arch Dis Child       Date:  1986-02       Impact factor: 3.791

Review 8.  Immune Complexes in Juvenile Idiopathic Arthritis.

Authors:  Terry L Moore
Journal:  Front Immunol       Date:  2016-05-20       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.